Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: Current status

Sam B. Bhayani, Mohamad E. Allaf, Louis R. Kavoussi

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

The purpose of the study was to update the current status of laparoscopic retroperitoneal lymph node dissection in the treatment of clinical Stage I nonseminomatous germ cell testicular cancer. A literature search was conducted to evaluate laparoscopic retroperitoneal lymph node dissection (RPLND) in comparison to other modalities of treatment. All treatment modalities are effective in treating clinical Stage I nonseminomatous germ cell tumors. Morbidity is the major issue that may guide treatment decisions. Laparoscopic RPLND, in its therapeutic form, may replicate open RPLND with a minimally invasive approach. Laparoscopic RPLND is an effective alternative to traditional treatment options.

Original languageEnglish
Pages (from-to)145-148
Number of pages4
JournalUrologic Oncology: Seminars and Original Investigations
Volume22
Issue number2
DOIs
StatePublished - Mar 1 2004

Keywords

  • Germ cell tumor
  • Lymphadenectomy
  • Retroperitoneal lymph node dissection
  • Testis cancer

Fingerprint Dive into the research topics of 'Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: Current status'. Together they form a unique fingerprint.

  • Cite this